Mumbai, January 2025: Integris, a globally diversified medical technology company, appoints Sanjeev Kumar as its Group Chief Financial Officer, effective Feb 3, 2025. Based in New Delhi, Sanjeev will report to the Group CEO, Probir Das and will play a key role in driving the company’s next phase of accelerated growth and innovation.
Integris, backed by Everstone Capital and its promoters Gurmit Chugh & Punita Arora, operates in 4 key segments within cardiovascular devices and in-vitro diagnostics across India, Southeast Asia, Europe, Middle East and Latin America.
Probir Das, Group CEO, Integris, said, “Sanjeev’s impressive track record in leading finance functions for large businesses, combined with his expertise in navigating successful IPOs in India, makes him an invaluable addition to our team. We look forward to his strategic guidance in driving Integris’ financial strategy and sustainable growth.”
“I am excited to join Integris and contribute to the company’s vision of delivering innovative medical technology-based solutions. I look forward to fostering a balance between growth orientation, operational efficiency, and strong compliance.” Sanjeev added.
With over three decades of experience in finance, Sanjeev has held key leadership roles at Bharti Airtel Limited and InterGlobe Enterprises Limited. Most recently, he served as the Group Chief Financial Officer at Medanta – The Medicity, where he led India’s largest IPO in the hospital sector and significantly expanded profit margins. An alumnus of Shri Ram College of Commerce, University of Delhi, Sanjeev is also an ICAI-certified Chartered Accountant and a Company Secretary. He has recently completed Harvard’s Advanced Management Programme.
About Integris:
Integris is a diversified MedTech platform with four significant business segments: Clinical Diagnostics, Scientific Lab Solutions, Cardiovascular Devices, and Vascular Access Therapies. The platform provides a strong product development and manufacturing core coupled with an unparalleled access to customers across India, Southeast Asia, Europe, Latam and the Middle East, serving diverse sets of customers across multiple therapeutic areas within the treatment continuum.
About Everstone Capital: Everstone Capital is the Private Equity business of the Everstone Group, a global firm with assets under management of over $8Bn committed to driving economic growth and creating sustainable value in India and Southeast Asia with a mission to build great businesses with extraordinary people. Everstone Capital is focused on mid-market, control growth and crossborder opportunities across Technology, Healthcare, Financial Services, and Industrials.
Website: https://everstonecapital.com/
Media contact:
Shubhangi Chaturvedi
9619821154 / corpcomm@everstonegroup.com